Interestingly, when RAS (KRAS/NRAS)-mutated CRC tumors were associated with combined AP mutations (i.e., APK mutations), the CTX-S scores were significantly higher (see Figure S2B). This evidence concerns the gene KRAS and colorectal carcinoma.